ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,70%(-0,017) 1D
20 қар., 17:29:34 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 м.
Volume
286,21 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 м.
Volume
286,21 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
AP News
·
15 сағат бұрын
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
6 сағат бұрын
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Beinsure
·
4 сағат бұрын
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Scripps News
·
7 сағат бұрын
AI stock sell-off sends S&P 500 into correction, Nasdaq negative for year
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com